We are live on ! Find out more
COLL icon

Collegium Pharmaceutical
COLL

60 hedge funds and large institutions have $327M invested in Collegium Pharmaceutical in 2015 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 21 increasing their positions, 13 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

275% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 4

62% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 13

44% more capital invested

Capital invested by funds: $227M → $327M (+$100M)

33% more funds holding in top 10

Funds holding in top 10: 3 → 4 (+1)

22% more funds holding

Funds holding: 49 → 60 (+11)

Holders
60
Holders Change
+11
Holders Change %
+22.45%
% of All Funds
1.57%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.1%
New
15
Increased
21
Reduced
13
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BFA
BlackRock Fund Advisors
California
+$5.13M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$2.74M
3
EAM
Eventide Asset Management
Massachusetts
+$1.92M
4
HM
HealthCor Management
New York
+$1.58M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$1.29M

Top Sellers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
-$14.7M
2
Westfield Capital Management
Westfield Capital Management
Massachusetts
-$4.08M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$3.52M
4
EMG
Ellington Management Group
Connecticut
-$604K
5
Renaissance Technologies
Renaissance Technologies
New York
-$419K
Name Holding Trade Value Shares
Change 		Change in
Stake
RFC
26
Russell Frank Company
Washington
$1M – – –
BLM
27
Bennett Lawrence Management
New York
$987K -$7.48K -355 -1%
TCIM
28
TIAA CREF Investment Management
New York
$777K +$52.6K +2,498 +10%
Bank of New York Mellon
29
Bank of New York Mellon
New York
$739K – – –
Morgan Stanley
30
Morgan Stanley
New York
$701K +$537K +25,505 New
BIM
31
BlackRock Investment Management
Delaware
$674K -$12.4K -587 -2%
ProShare Advisors
32
ProShare Advisors
Maryland
$484K +$371K +17,605 New
California State Teachers Retirement System (CalSTRS)
33
California State Teachers Retirement System (CalSTRS)
California
$341K +$4.21K +200 +2%
Renaissance Technologies
34
Renaissance Technologies
New York
$328K -$419K -19,867 -62%
MWP
35
MYCIO Wealth Partners
Pennsylvania
$303K +$126K +6,000 +120%
D.E. Shaw & Co
36
D.E. Shaw & Co
New York
$270K +$207K +9,804 New
TA
37
Teachers Advisors
New York
$265K – – –
Charles Schwab
38
Charles Schwab
California
$241K +$184K +8,736 New
PAM
39
Panagora Asset Management
Massachusetts
$240K +$184K +8,742 New
Two Sigma Investments
40
Two Sigma Investments
New York
$234K +$179K +8,500 New
New York State Common Retirement Fund
41
New York State Common Retirement Fund
New York
$168K – – –
Wells Fargo
42
Wells Fargo
California
$157K +$119K +5,668 +17,176%
Citigroup
43
Citigroup
New York
$133K +$102K +4,840 +484,000%
NFA
44
Nationwide Fund Advisors
Ohio
$117K – – –
Deutsche Bank
45
Deutsche Bank
Germany
$116K -$337K -15,984 -79%
AIG
46
American International Group
New York
$107K -$147 -7 -0.2%
BA
47
BlackRock Advisors
Delaware
$64K -$22.8K -1,083 -32%
UBS Group
48
UBS Group
Switzerland
$63K +$37.8K +1,792 +358%
SO
49
STRS Ohio
Ohio
$57K – – –
BNP Paribas Financial Markets
50
BNP Paribas Financial Markets
France
$38.4K +$421 +20 +1%
1
2
3

COLL Hedge Fund Activity: Q4 2015 in Review

60 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Collegium Pharmaceutical (COLL) for Q4 2015, worth a combined $327M — up 44% from $227M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new COLL positions and 4 closed out — a net gain of 11 holders — while 21 added to existing stakes and 13 trimmed.

The largest buyer was BlackRock Fund Advisors, adding an estimated $5.13M. The largest seller was RA Capital Management, cutting an estimated $14.7M.

  • 60 institutional investors held Collegium Pharmaceutical (COLL) as of Q4 2015, up from 49 in Q3 2015.
  • Funds reported $327M of Collegium Pharmaceutical stock for Q4 2015, up 44% quarter-over-quarter.
  • 15 funds opened new Collegium Pharmaceutical positions in Q4 2015 and 4 closed out, a net change of +11 holders.
  • The largest Collegium Pharmaceutical buyer in Q4 2015 was BlackRock Fund Advisors, an estimated $5.13M added.
  • The largest Collegium Pharmaceutical seller in Q4 2015 was RA Capital Management, an estimated $14.7M sold.

Based on aggregated 13F filings for Q4 2015.